A Study of C-CAR039 (Prizloncabtagene Autoleucel) in Patients With Relapsed/Refractory Large B-Cell Lymphoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of C-CAR039 (Prizloncabtagene Autoleucel) in Patients With Relapsed/Refractory Large B-Cell Lymphoma	Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence	Recruiting	Phase 1 / Phase 2	2025-12-31		NCT05800977

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Shanghai AbelZeta Ltd.	9

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beijing Cancer Hospital	Beijing	China	85
Beijing Gobroad Hospital	Beijing	China	10
Cancer Hospital of Shandong First Medical University	Jinan	China	12
Chinese Academy of Medical Sciences Hematology Hospital	Tianjin	China	1
Chongqing University Cancer Hospital	Chongqing	China	17
Guangdong Provincial People's Hospital	Guangzhou	China	37
Henan Cancer Hospital	Zhengzhou	China	60
Jiangsu Province Hospital	Nanjing	China	39
Jiangxi Cancer Hospital	Nanchang	China	18
Peking University Third Hospital	Beijing	China	71
Ruijin Hospital, Shanghai Jiaotong University School of Medicine	Shanghai	China	21
The First Affiliated Hospital of Zhengzhou University	Zhengzhou	China	61
The First Affiliated Hospital Zhejiang University School of Medicine	Hangzhou	China	8
Tianjin Medical University Cancer Institute& Hospital	Tianjin	China	1
Zhujiang Hospital of Southern Medical University	Guangzhou	China	7